Counterfeiting is no longer happening in the shadows. Fake products sit right next to genuine ones, often convincing enough to fool the most loyal buyer. For brands in the pharmaceutical sector, this is more than a commercial threat. It risks consumer safety and long-term brand trust. A recent case handled by BrandProCare shows just how quickly a brand can slip into a crisis without early detection and how a strategic market survey prevented a loss that could have run into multiple crores.
Where It Started
A well-known pharmaceutical brand began noticing a surprising dip in sales in certain northern Indian markets. There were no supply chain disruptions, no pricing changes, and no marketing slowdown. Everything on paper looked normal, yet the numbers told a different story. The brand first suspected distribution inefficiencies, but nothing indicated a failure there either. Something felt off, but the data wasn’t revealing the cause.
This is where BrandProCare stepped in. Rather than relying on assumptions, we recommended a structured market survey to understand what was happening at the retail level.
What the Market Survey Found
Teams were deployed across tier-1 and tier-2 cities, visiting pharmacies, chemists, and wholesale hubs. The goal was simple: understand real-time product movement and identify anything unusual.
The findings were alarming.
Several retail outlets were stocking lookalike versions of the brand’s flagship drug. These counterfeits had nearly identical packaging, right down to the QR style layout and colour scheme. Customers had no way to tell the difference unless they knew what to look for. Even more concerning, retailers were choosing the fake product because it came with a much higher margin.
Here are the observations that stood out:
- Counterfeits were concentrated in high-sales territories
- Distributors supplying these fakes were operating parallel channels
- Retailers admitted they believed customers would not notice the switch
- The packaging carried a fake batch number and expiry date
- The counterfeit variant had not gone through standard regulatory approvals
The survey made one thing clear. The problem was not minor. It was spreading.
How Serious Was the Damage?
Based on sampling from surveyed markets, counterfeit sales were already eating into nearly 18 percent of the brand’s revenue in those territories. If the trend had continued for another 6 to 9 months, projections estimated a multi-crore loss. Apart from revenue, there was another threat building silently. Consumers who used the fake version were likely to blame the real brand if it didn’t work or caused side effects.
So the damage was not limited to numbers. It could have impacted the brand’s trust, reputation, and regulatory compliance.
Action After Detection
The findings helped the brand take decisive action without losing time. With clear data in hand, the company could move in multiple directions at once. Below is how the action unfolded:
- Enforcement and legal teams coordinated with authorities for raid planning
- Distributors responsible for circulating fakes were mapped geographically
- Packaging weaknesses were identified and updated for future production
- Retailers were informed through awareness campaigns
- A digital authentication solution through QR verification was introduced
- Investigation efforts continued until the root supply source was found
Once raids were executed, thousands of counterfeit strips and bulk stock were seized. The circulation network was traced back to a smaller manufacturer operating without licenses. Legal action followed. Counterfeit supply reduced sharply within weeks.
The Bigger Picture
If the market survey had not been deployed at the right time, the brand could have spent months guessing the cause of declining revenue. Worse, the counterfeiting network would have penetrated deeper into the supply chain. By that point, even a massive intervention might not have been enough to reverse the damage.
Market surveys are sometimes misunderstood as an added expense or as a tool meant only for brand positioning and customer behaviour. This case proved something different. They are also one of the most reliable early warning systems for brand protection. They reveal what happens on the ground long before the damage shows up in quarterly reports.
What Other Brands Can Learn
The pharmaceutical sector is especially vulnerable. Products that are in high demand and depend on consumer trust are often the first target for counterfeiters. The learning here is not limited to one brand. Any company manufacturing widely used medicines should recognise the signs early.
Below are some red flags that should never be ignored:
- Sudden sales drop in a specific geography
- Retailer feedback on “new supply” at higher margins
- Online distributors offering bulk stock at unusually low rates
- Customer complaints that are clinically inconsistent
- Packaging differences observed during internal audits
Detecting counterfeit circulation early can save a company not only from financial loss but from market distrust that can take years to rebuild.
Why Market Surveys Matter More Than Ever
Technology is helping counterfeiters improve their quality and reach. That means brands need to stay ahead. Market surveys do not replace enforcement, legal action, or digital authentication tools. Instead, they support all of them. They provide visibility at the point where misuse actually happens. Most importantly, they turn suspicion into evidence.
Closing Thought
This real case showed one truth very clearly. Brands may invest years building trust, but counterfeiters need only a few months to damage it. Market surveys gave the pharmaceutical brand the information it needed at the exact moment it mattered. What could have become a silent multi-crore loss was stopped before it spiralled.
For brands that rely on customer trust and product reliability, staying alert is not optional. Early detection is the difference between protection and loss.





